Acetaldehyde inhibits serum aminopeptidases

Alcohol

Volumn 13, Issue 2, 1996, Pages 125-131

  Brecher, Arthur S ^a   Stauffer, Ross ^a   Knight, Joy ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

Alcohol; Alcoholism; Aminopeptidase A; Angiotensin II; Angiotensinases; Arylamidases; High blood pressure; Hypertension; Naphthylamidases

Indexed keywords

ACETALDEHYDE; AMINOPEPTIDASE; ANGIOTENSIN; MICROSOMAL AMINOPEPTIDASE;

ALCOHOL METABOLISM; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HYPERTENSION; SERUM;

EID: 0029998958     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/0741-8329(95)02023-3     Document Type: Article

References (63)

1. Barrett, A. J. Introduction to the history and classification of tissue proteinases. In: Barrett, A. J., ed. Proteinases in mammalian cells and tissues. Amsterdam: North-Holland; 1977:1-55.
2. Basista, M. H.; Joseph, A.; Smolen, S.; Koterba, A.; Brecher, A. S. Acetaldehyde alters coagulation protein function. Dig. Dis. Sci. 39:2421-2425; 1994.
3. Brecher, A. S.; Koterba, A.; Basista, M. H. Acetaldehyde inhibits the activation of prothrombin by Echis carinatus. Abstract #RGA11. Central Society for Clinical Research, Chicago, IL, Sept. 28-30, 1995.
4. Brecher, A. S.; Suszkiw, J. B. Brain arylamidase. Biochem. J. 112:335-342; 1969.
5. Brody, M. J.; Faber, J. E.; Mangiapane, M. M.; Porter, J. P. In: Ong, H. H.; Lewis, J. C., eds. Hypertension. Physiological basis and treatment. Orlando: Academic Press, Inc.; 1984.
6. Cheung, H. S.; Cushman, D. W. A soluble aspartate aminopeptidase from dog kidney. Biochim. Biophys. Acta 242:190-193; 1971.
7. Collins, G. B.; Brosnihan, K. B.; Messina, M.; Gupta, M. K. Neuroendocrine, fluid balance, and thirst response to alcohol in alcoholics. Alcoholism 16:228-233; 1992.
8. Delange, R. J.; Smith, E. L. Leucineaminopeptidase and other N-terminal exopeptidases. In: Boyer, P. D., ed. The enzymes, vol. III, 3rd ed. New York: Academic Press; 1971:81-118.
9. Ellis, S.; Perry, M. Pituitary arylamidases and peptidases. J. Biol. Chem. 241:3679-3686; 1966.
10. Fitts, D. A. Angiotensin and captopril increase alcohol intake. Pharmacol. Biochem. Behav. 45:35-43; 1993.
11. Fraenkel-Conrat, H.; Brandon, B. A.; Olcott, H. S. The reaction of formaldehyde with proteins IV. Participation of indole groups. Gramicidin J. Biol. Chem. 168:99-118; 1947.
12. Fraenkel-Conrat, H.; Cooper, M.; Olcott, H. S. The reaction of formaldehyde with proteins. J. Am. Chem. Soc. 67:950-954; 1945.
13. Fraenkel-Conrat, H.; Olcott, H. S. The reaction of formaldehyde with proteins. V. Cross-linking between amino and primary amide or guanidyl groups. J. Am. Chem. Soc. 70:2673-2684; 1945.
14. Fraenkel-Conrat, H.; Olcott, H. S. Reaction of formaldehyde with proteins. VI. Cross-linking of amino groups with phenol, imidazole, or indole groups. J. Biol. Chem. 174:827-843; 1948.
15. Fukui, T.; Kamogawa, A.; Nikuni, Z. Reaction of glyoxal with α-glycan phosphorylases from potato and rabbit muscle. J. Biochem. (Tokyo) 67:211-218; 1970.
16. Glenner, G. G.; McMillan, P. M. Y.; Folk. J. E. A mammalian peptidase specific for the hydrolysis of N-terminal α-L-glutamyl and aspartyl residues. Nature 194:867; 1962.
17. Goodfriend, T. L. Angiotensin receptors and specific functions of angiotensins I, II, and III. In: Genest, J.; Kuchel, O.; Hamet, P.; Contin, M., eds. Hypertension physiopathology and treatment. 2nd ed. New York: McGraw-Hill; 1983:271-279.
18. Grupp, L. A. Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats. Pharmacol. Biochem. Behav. 41:105-108; 1992.
19. 1 receptor subtype. Pharmacol. Biochem. Behav. 47:385-92; 1994.
20. Grupp, L. A.; Killian, M.; Perlanski, E.; Stewart, R. B. Angiotensin II reduces voluntary alcohol intake in the rat. Pharmacol. Biochem. Behav. 29:479-482; 1988.
21. Grupp, A.; Perlanski, E.; Leenen, F. H. H.; Stewart, R. B. Renal artery stenosis: An example of how the periphery can modulate voluntary alcohol drinking. Life Sci. 40:563-570; 1987.
22. Grupp, L. A.; Perlanski, E.; Leenen, F. H. H.; Stewart, R. B. Voluntary alcohol intake is attenuated in two-kidney, one-clip but not in one-kidney, one-clip Goldblatt hypertensive rats. Alcohol 5:173-179; 1988.
23. Grupp, L. A.; Perlanski, E.; Stewart, R. B. Dietary salt and DOCA-salt treatments modify ethanol self-selection in rats. Behav. Neural Biol. 40:239-250; 1984.
24. Grupp, L. A.; Perlanski, E.; Stewart, R. B. Diet and diuretics in the reduction of voluntary alcohol drinking in rats. Alcohol 21: 75-80; 1986.
25. Grupp, L. A.; Perlanski, E.; Stewart, R. B. Attenuation of alcohol intake by a serotonin uptake inhibitor: Evidence for mediation through the renin-angiotensin system. Pharmacol. Biochem. Behav. 30:823-827; 1988.
26. 8 angiotensin II. Pharmacol. Biochem. Behav. 31:813-816; 1989.
27. Grupp, L. A.; Perlanski, E.; Stewart, R. B. Systemic angiotensin II acts at the subfornical organ to suppress voluntary alcohol consumption. Pharmacol. Biochem. Behav. 34:201-205; 1989.
28. Grupp, L. A.; Perlanski, E.; Stewart, R. B. Regulation of alcohol comsumption by the renin-angiotensin system: A review of recent findings and a possible mechanism of action. Neurosci. Biobehav. Rev. 15:265-275; 1991.
29. Grupp, L. A.; Perlanski, E.; Wanless, I. R.; Stewart, R. B. Voluntary alcohol intake in the hypertension prone Dahl rat. Pharmacol. Biochem. Behav. 24:1167-1174; 1986.
30. Grupp, L. A.; Sneddon, B.; Solway, E.; Perlanski, E.; Stewart, R. B. The beta-adrenergic agonist isoproterenol suppressed voluntary alcohol intake in rats. Pharmacol. Biochem. Behav. 33: 493-495; 1989.
31. Grupp, L. A.; Stewart, R. B.; Perlanski, E. Salt restriction and the voluntary intake of ethanol in rats. Physiol. Psychol. 12:242-246; 1984.
32. Haber, E.; Carlson, W. The biochemistry of the renin-angiotensin system. In: Genest, J.; Kuchel, O.; Hamet, P.; Cantin, M.; eds. Hypertension physiopathology and treatment. 2nd ed. New York: McGraw-Hill; 1983:170-184.
33. Hanson, H.; Glasser, D.; Ludewig, M.; Mannsfeldt, H.-G.; John, M.; Nesvadba, H. Structure and activity specificity of leucine aminopeptidase from pig kidneys and bovine lenses and comparison with the particulate aminopeptidase from pig kidneys. Hoppe Seyler's Z. Physiol. Chem. 348:689-704; 1967.
34. Hatake, K.; Taniguchi, T.; Ouchi, H.; Sakaki, N.; Hishida, S.; Ijiri, I. Possible involvement of kinins in cardiovascular changes after alcohol intake. Pharmacol. Biochem. Behav. 35:437-442; 1990.
35. Hernàndez-Munoz, R.; Ma, X.-L.; Baraone, E.; Lieber, C. S. Method of acetaldehyde measurement with minimal artifactual formation in red blood cells and plasma of actively drinking subjects with alcoholism. J. Lab. Clin. Med. 120:35-41; 1992.
36. Hopsu, V. K.; Kantonen, U.-M.; Glenner, G. G. A peptidase from rat tissues selectively hydrolyzing N-terminal arginine and lysine residues. Life Sci. 3:1449-1453; 1964.
37. Hopsu, V. K.; Makinen, K. K.; Glenner, G. G. Purification of a mammalian peptidase selective for N-terminal arginine and lysine residues: Aminopeptidase B. Arch. Biochem. Biophys. 114:557-566; 1966.
38. Hubbel, C. L.; Chrisbacher, G. A.; Bilsky, E. J.; Reid, L. D. Manipulations of the renin-angiotensin system and intake of a sweetened alcoholic beverage among rats. Alcohol 9:53-61; 1991.
39. Johnson, D. C.; Ryan, J. W. Degradation of angtiotensin II by a carboxypeptidase of rabbit liver. Biochim. Biophys. Acta 160: 196-203; 1968.
40. Kaysen, G.; Noth, R. H. The effects of alcohol on blood pressure and electrolytes. Med. Clin. North Am. 68:221-246; 1984.
41. Kenny, A. J. Proteinases associated with cell membranes. In: Barrett, A. J., ed. Proteinases in mammalian cells and tissues. Amsterdam: North-Holland; 1977:393-444.
42. Khairallah, P. A.; Page, I. H. Plasma angiotensinases. Biochem. Med. 1:1-8; 1967.
43. Koterba, A. P.; Smolen, S.; Joseph, A.; Basista, M. H.; Brecher, A. S. Coagulation protein function. II. Influence of thiols upon acetaldehyde effects. Alcohol 12:49-57; 1995.
44. Kugler, P. On angiotensin-degrading aminopeptidases in the rat kidney. Adv. Anat. Embryol. Cell Biol. 76:1-86; 1982.
45. Ledingham, J. G.; Leary, W. P. Catabolism of angiotensin II. In: Page, I. H.; Bumpus, F. M., eds. Angiotensin. Berlin: Springer; 1974:111-125.
46. Lingham, T.; Perlanski, E.; Grupp, L. A. Angiotensin converting enzyme inhibitors reduce alcohol consumption: Some possible mechanisms and important conditions for its therapeutic use. Alcohol. Clin. Exp. Res. 14:92-99; 1990.
47. Matsunaga, M. Nature of lysosomal angiotensinase activity. Jpn. Circ. J. 35:333-338; 1971.
48. McDonald, J. K.; Ellis, S.; Reilly, T. J. Properties of dipeptidyl arylamidase I of the pituitary chloride and sulfhydryl activation of seryltyrosyl-β-napnthylamide hydrolysis. J. Biol. Chem. 241: 1494-1501; 1966.
49. McDonald, J. K.; Reily, T. J.; Ellis, S. The hydrolysis of amino acyl β-naphthylamides by plasma aminopeptidases. Biochem. Biophys. Res. Commun. 16:135-140; 1964.
50. McDonald, J. K.; Schwabe, C. Intracellular exopeptidases. In: Barrett, A. J., ed. Proteinases in mammalian cells and tissues. Amsterdam: North-Holland; 1977:311-391.
51. Nagatsu, I. T.; Gillespie, I. L.; George, J. M.; Folk, J. E.; Glenner, G. G. Serum aminopeptidase "angiotensinase" and hypertension II. Amino acid β-naphthylamide hydrolysis by normal and hypertensive serum. Biochem. Pharmacol. 14:853-861; 1965.
52. Nagatsu, I. T.; Yamamoto, T.; Glenner, G. G.; Mehl, J. W. Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim. Biophys. Acta 198:255-270; 1970.
53. Naranjo, C. A.; Kadlec, K. E.; Sanhuenza, P.; Woodley-Remus, D.; Sellers, E. M. Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics. Clin. Pharmacol. Ther. 50:96-106; 1991.
54. Page, L. B. Epidemiology of hypertension. In: Genest, J.; Kuchel, O.; Hamet, P.; Cantin, M., eds. Hypertension. New York: McGraw-Hill; 1983:683-699.
55. Peart, W. S. General review of hypertension. In: Genest, J.; Kuchel, O.; Hamet, P.; Cantin, M., eds. Hypertension. New York: McGraw-Hill; 1983:3-14.
56. Ratner, S.; Clarke, H. T. The action of formaldehyde upon cysteine. J. Am. Chem. Soc. 59:200-206; 1937.
57. Regoli, D.; Riniker, B.; Brunner, H. R. The enzymatic degradation of various angiotensin II derivatives by serum, plasma or kidney homogenates. Biochem. Pharmacol. 12:637-646; 1963.
58. Saab, G.; Robertson, J. M.; Harding, S.; Grupp, L. A. Adrenalectomy does not modify the suppressive effect of angiotensin II on voluntary ethanol drinking in rats. Eur. J. Pharmacol. 256:1-7; 1994.
59. Spinosa, G.; Perlanski, E.; Leenen, F. H. H.; Stewart, R. B.; Grupp, L. A. Angiotensin converting enzyme inhibitors: Animal experiments suggest a new pharmacological treatment for alcohol abuse in humans. Alcohol. Clin. Exp. Res. 12:65-70; 1988.
60. Thevananther, S.; Brecher, A. S. Acetaldehyde inhibits angiotensin-converting enzyme activity of bovine lung. Alcohol. 10:545-548; 1993.
61. Thevananther, S.; Brecher, A. S. Interaction of acetaldehyde with plasma proteins of the renin-angiotensin system. Alcohol 11:493-499; 1994.
62. Wachsmuth, E. D.; Fritze, I.; Pfleiderer, G. An aminopeptidase occurring in pig kidney. I. An improved method of preparation. Physical and enzymic properties. Biochemistry 5:169-174; 1966.
63. Yang, H. Y. T.; Erdös, E. G.; Chiang, T. S. New enzymatic route for the inactivation of angiotensin. Nature 218:1224-1225; 1968.